Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alex azar
alliance for aging research
amgen
biogen
biotechnology innovation organization
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
drug pricing
duane schulthess
eli lilly
erica whittaker
fda
indiana blog main
indiana top stories
jim greenwood
life sciences
medicaid
medicare
1
×
nancy pelosi
natalizumab
1
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
regeneron pharmaceuticals
1
×
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
1
×
seattle blog main
seattle top stories
susan peschin
texas blog main
What
administration
angry
anti
benefited
despite
drug
fear
industry
losing
pharma
plans
presidential
price
rhetoric
rx
scalps
split
thanks
trump
tweets
Language
Current search:
natalizumab
×
medicare
×
" regeneron pharmaceuticals "
×
" san francisco top stories "
×
@xconomy.com
5 years ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans